Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy).
Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, Sweeny J, Maehara A, Mehran R, Dangas G, Mintz GS, Fuster V, Narula J, Sharma SK, Moreno PR. Kini AS, et al. Among authors: limaye a. J Am Coll Cardiol. 2013 Jul 2;62(1):21-9. doi: 10.1016/j.jacc.2013.03.058. Epub 2013 May 1. J Am Coll Cardiol. 2013. PMID: 23644090 Free article. Clinical Trial.
The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study.
Dohi T, Maehara A, Moreno PR, Baber U, Kovacic JC, Limaye AM, Ali ZA, Sweeny JM, Mehran R, Dangas GD, Xu K, Sharma SK, Mintz GS, Kini AS. Dohi T, et al. Among authors: limaye am. Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):81-7. doi: 10.1093/ehjci/jeu169. Epub 2014 Sep 4. Eur Heart J Cardiovasc Imaging. 2015. PMID: 25190072 Free PMC article. Clinical Trial.
Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: competing factors influence mortality, myocardial infarction, and target lesion revascularization.
Kovacic JC, Limaye AM, Sartori S, Lee P, Patel R, Chandela S, Trost B, Roy S, Harari R, Narechania B, Karajgikar R, Kim MC, Krishnan P, Moreno P, Baber U, Mehran R, Dangas G, Kini AS, Sharma SK. Kovacic JC, et al. Catheter Cardiovasc Interv. 2013 Nov 15;82(6):855-68. doi: 10.1002/ccd.25008. Epub 2013 Jul 1. Catheter Cardiovasc Interv. 2013. PMID: 23703934 Free PMC article.
A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy.
Imlay H, Gnann JW Jr, Rooney J, Peddi VR, Wiseman AC, Josephson MA, Kew C, Young JH, Adey DB, Samaniego-Picota M, Whitley RJ, Limaye AP. Imlay H, et al. Among authors: limaye ap. Transpl Infect Dis. 2024 Dec;26(6):e14367. doi: 10.1111/tid.14367. Epub 2024 Sep 3. Transpl Infect Dis. 2024. PMID: 39226143 Free PMC article. Clinical Trial.
3D revisualization: a new method to revisit segmented data.
Hu Y, Limaye A, Lu J. Hu Y, et al. Among authors: limaye a. R Soc Open Sci. 2024 Jun 12;11(6):240375. doi: 10.1098/rsos.240375. eCollection 2024 Jun. R Soc Open Sci. 2024. PMID: 39100145 Free PMC article.
383 results